Clinical trials

To determine the safety and effectiveness of IMPEDE-FX RapidFill to increase the percentage of subjects with shrinkage of the abdominal aortic aneurysm sac when used as an adjunct to on-label endovascular aneurysm repair (EVAR) stent graft treatment in trial subjects considered candidates for elective EVAR.

To determine the safety and feasibility of the investigational product to reduce aortic dissection false lumen perfusion.

To determine the safety and feasibility of the investigational product to reduce aortic dissection false lumen perfusion.

To determine the safety and feasibility of investigational product to reduce aortic dissection false lumen perfusion.